United States · FDA National Drug Code directory
Bendamustine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-6228_75bee9ee-7dde-ac1b-47c0-05f247c7bee1
- Product NDC
- 60505-6228
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Bendamustine Hydrochloride
- Labeler
- Apotex Corp
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230426
- Source listing expiry
- 20271231
Source-listed ingredients
- BENDAMUSTINE HYDROCHLORIDE — 25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (60505-6228-0) / 5 mL in 1 VIAL, MULTI-DOSE · 60505-6228-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →